Email updates

Keep up to date with the latest news and content from BMC Immunology and BioMed Central.

This article is part of the supplement: Proceedings of Delivery Systems and Current Strategies to Drug Design

Open Access Email this article to a friend

New proteoliposome vaccine formulation from N. meningitidis serogroup B, without aluminum hydroxide, retains its antimeningococcal protectogenic potential as well as Th-1 adjuvant capacity

Beatriz Tamargo, Yanet Márquez, Wendy Ramírez, Bárbara Cedré, Manuel Fresno and Gustavo Sierra*

BMC Immunology 2013, 14(Suppl 1):S12  doi:10.1186/1471-2172-14-S1-S12

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Immunology's emails?